Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jul;45(7):2106-9.
doi: 10.1128/AAC.45.7.2106-2109.2001.

Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand

Affiliations

Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand

H Noedl et al. Antimicrob Agents Chemother. 2001 Jul.

Abstract

Desbutyl-benflumetol (DBB) is a novel antimalarial compound closely related to benflumetol (lumefantrine), of which it is a putative metabolite. The in vitro response of Plasmodium falciparum to DBB was studied in Mae Hong Son and Mae Sot, in northwest Thailand, in 1997 and 1998. In total, 155 fresh isolates were successfully tested using the World Health Organization standard in vitro microtest system (Mark II). The mean 50% effective concentration (EC(50)) and 90% effective concentration of DBB were 6.36 and 31.09 nmol/liter, respectively. The comparison of the activity of DBB and benflumetol yielded a highly significant potency ratio of 4.52, corresponding to a more than four times higher efficacy of DBB. A considerable potency difference was found between isolates from Mae Hong Son and those from Mae Sot, reflecting lesser sensitivity in the area with marked resistance to mefloquine and quinine. This observation is also supported by a highly significant activity correlation with benflumetol (P < 0.001) and to a similar degree with mefloquine (P < 0.001), reflecting a close relationship of DBB with the class II aryl amino alcohol blood schizontocides. A less distinct association was also found with artemisinin, which was significant only at the EC(50) level, and there was no correlation at all with chloroquine. DBB is a promising antimalarial compound that merits further investigation in order to define its practical therapeutic potential.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Chemical structure of DBB. DBB is a 2,3-benzindene and is closely related to benflumetol (lumefantrine).
FIG. 2
FIG. 2
Mean concentration response (SMI%) lines of DBB for the years 1997 and 1998 for P. falciparum from Mae Hong Son (MHS) and Mae Sot (MS), with data points. Higher EC values from Mae Sot are indicated by the flatter regression line. The mean EC50 from Mae Sot in 1998 (MS 98) was found to be significantly higher than the corresponding value from Mae Hong Son (MHS 98).
FIG. 3
FIG. 3
Mean concentration response (SMI%) lines for DBB and benflumetol (BEN) for P. falciparum, with 95% confidence intervals and data points. Parallel pooled data (n = 154) of 1997 and 1998 in Thailand are shown. The position of the regression line and the smaller number of data points reflect the higher activity of DBB.
FIG. 4
FIG. 4
Scatter diagram of individual EC50 values for DBB and benflumetol (BEN) for P. falciparum from Thailand, 1997 and 1998 (n = 154), showing distinct correlation and reflecting the close relationship between benflumetol and DBB. Concentrations are in nanomoles per liter.

Similar articles

Cited by

References

    1. Alin M H, Björkman A, Wernsdorfer W H. Synergism of benflumetol and artemether in Plasmodium falciparum. Am J Trop Med Hyg. 1999;61:439–445. - PubMed
    1. Ezzet F, Mull R, Karbwang J. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Br J Clin Pharmacol. 1998;46:553–561. - PMC - PubMed
    1. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White N J. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother. 2000;44:697–704. - PMC - PubMed
    1. Hatz C, Abdulla S, Mull R, Schellenberg D, Gathmann I, Kibatala P, Beck H-P, Tanner M, Royce C. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1–5 years. Trop Med Int Health. 1998;3:498–504. - PubMed
    1. Jiao X, Liu G, Shan C O, Li X W, Gathmann I, Royce C. Phase II trial in China of a new, rapidly-acting and oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria. Southeast Asian J Trop Med Public Health. 1997;28:476–481. - PubMed

Publication types

LinkOut - more resources